NL7202278A - - Google Patents

Info

Publication number
NL7202278A
NL7202278A NL7202278A NL7202278A NL7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A
Authority
NL
Netherlands
Application number
NL7202278A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE795788D priority Critical patent/BE795788A/xx
Application filed filed Critical
Priority to NL7202278A priority patent/NL7202278A/xx
Priority to ZA730839A priority patent/ZA73839B/xx
Priority to GB621973A priority patent/GB1416271A/en
Priority to AU51979/73A priority patent/AU471298B2/en
Priority to US00331945A priority patent/US3853836A/en
Priority to DE19732308362 priority patent/DE2308362A1/de
Priority to HUAO351A priority patent/HU168890B/hu
Priority to JP48021120A priority patent/JPS4896586A/ja
Priority to CA164,274A priority patent/CA1030953A/en
Priority to CH245873A priority patent/CH585192A5/xx
Priority to FR7306338A priority patent/FR2181759B1/fr
Publication of NL7202278A publication Critical patent/NL7202278A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
NL7202278A 1972-02-22 1972-02-22 NL7202278A (xx)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BE795788D BE795788A (nl) 1972-02-22 Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
NL7202278A NL7202278A (xx) 1972-02-22 1972-02-22
ZA730839A ZA73839B (en) 1972-02-22 1973-02-06 Psychopharmacologically active peptides
GB621973A GB1416271A (en) 1972-02-22 1973-02-08 Psychopharmacologically active peptides
AU51979/73A AU471298B2 (en) 1972-02-22 1973-02-08 Psychopharmacologically active peptides
US00331945A US3853836A (en) 1972-02-22 1973-02-12 Psychopharmacologically active peptides related to acth
DE19732308362 DE2308362A1 (de) 1972-02-22 1973-02-20 Psychopharmakologisch aktive peptide und peptidderivate
HUAO351A HU168890B (xx) 1972-02-22 1973-02-20
JP48021120A JPS4896586A (xx) 1972-02-22 1973-02-21
CA164,274A CA1030953A (en) 1972-02-22 1973-02-21 Psychopharmacologically active peptides
CH245873A CH585192A5 (xx) 1972-02-22 1973-02-21
FR7306338A FR2181759B1 (xx) 1972-02-22 1973-02-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7202278A NL7202278A (xx) 1972-02-22 1972-02-22

Publications (1)

Publication Number Publication Date
NL7202278A true NL7202278A (xx) 1973-08-24

Family

ID=19815436

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7202278A NL7202278A (xx) 1972-02-22 1972-02-22

Country Status (12)

Country Link
US (1) US3853836A (xx)
JP (1) JPS4896586A (xx)
AU (1) AU471298B2 (xx)
BE (1) BE795788A (xx)
CA (1) CA1030953A (xx)
CH (1) CH585192A5 (xx)
DE (1) DE2308362A1 (xx)
FR (1) FR2181759B1 (xx)
GB (1) GB1416271A (xx)
HU (1) HU168890B (xx)
NL (1) NL7202278A (xx)
ZA (1) ZA73839B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4623715A (en) 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
JP2525798B2 (ja) * 1987-03-12 1996-08-21 第一製薬株式会社 ペプチド誘導体
WO1993000922A1 (en) * 1991-07-01 1993-01-21 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
ES2294415T3 (es) * 2000-08-25 2008-04-01 Research Corporation Technologies, Inc Uso de aminoacidos anticonvulsionantes para el tratamiento de los trastornos bipolares.
CA2453515A1 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
PT1751273E (pt) 2004-04-08 2011-03-07 Astellas Pharma Inc Composto ws727713
AU2005231034B2 (en) * 2004-04-08 2010-04-08 Telsar Pharma Inc. Compound WS727713
ES2710617T3 (es) * 2010-04-21 2019-04-26 Signature Therapeutics Inc Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos
AU2021382158A1 (en) * 2020-11-18 2023-06-15 Mind Medicine, Inc. Mdma prodrugs to assist psychotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL278010A (xx) * 1961-05-04 1900-01-01
NL6509727A (xx) * 1965-07-28 1967-01-30
GB1230472A (xx) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
US3853836A (en) 1974-12-10
DE2308362A1 (de) 1973-09-06
GB1416271A (en) 1975-12-03
JPS4896586A (xx) 1973-12-10
CH585192A5 (xx) 1977-02-28
CA1030953A (en) 1978-05-09
AU471298B2 (en) 1976-04-15
BE795788A (nl) 1973-08-22
AU5197973A (en) 1974-08-08
ZA73839B (en) 1973-11-28
FR2181759A1 (xx) 1973-12-07
FR2181759B1 (xx) 1976-09-03
HU168890B (xx) 1976-08-28

Similar Documents

Publication Publication Date Title
USB344203I5 (xx)
FR2186643A1 (xx)
JPS4943589A (xx)
JPS4976890U (xx)
FR2213910B1 (xx)
FR2178688A5 (xx)
JPS4934728U (xx)
JPS5243334Y2 (xx)
JPS5219832Y2 (xx)
JPS5124307B2 (xx)
JPS5039155B2 (xx)
JPS4934362A (xx)
JPS5215775Y2 (xx)
JPS5149075Y2 (xx)
JPS5329829Y2 (xx)
JPS546710Y2 (xx)
JPS4928175A (xx)
JPS4985632U (xx)
JPS4981099A (xx)
JPS4960055U (xx)
JPS48109595U (xx)
CH576959A5 (xx)
CH572208A5 (xx)
NL7302049A (xx)
SE7110896L (xx)